What do u think our X earnings ratio would be come commercialisation? 10, 20, 30, 40? If we have some big indication potentials x 40 wouldnt be excessive. I doubt our drug will stop at dmd. Later this year those animal tests will give insight to how high up the earnings ratio we'll fly.
Chart, page-3846
-
- There are more pages in this discussion • 2,060 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
